Table 1.
Variable | Overall |
---|---|
Age (years) mean ± SD | 72 ± 11 |
Female sex, n (%) | 27 (38.6%) |
BMI (kg/m2), mean ± SD | 23.89 ± 3.59 |
Smoke, n (%) | 11 (15.7%) |
Diabetes mellitus, n (%) | 16 (22.9%) |
Hypertension, n (%) | 43 (61.4%) |
Atrial fibrillation, n (%) | 37 (52.9%) |
HCY, μmol/L, median (IQR) | 13.18 (10.13, 18.32) |
CRP, mg/L, median (IQR) | 6.88 (2.57, 31.26) |
BG on admission, mmol/L, median (IQR) | 7.3 (6.2, 8.8) |
FBG, mmol/L, median (IQR) | 7.17 (5.77, 9.15) |
HbA1c, % | 5.9 (5.5, 6.8) |
NIHSS on admission, point, median (IQR) | 18 (13, 21) |
NIHSS at 24 h, points, median (IQR) | 12 (5, 20) |
NIHSS at 7 days, points, median (IQR) | 7 (0, 15) |
Occluded artery | |
ICA, n (%) | 21 (30%) |
M1, n (%) | 40 (57.1%) |
M2, n (%) | 9 (12.9) |
TOAST | |
LAA, n (%) | 21 (30%) |
CE, n (%) | 40 (57.1%) |
SUE, n (%) | 9 (12.9%) |
ORT, min, median (IQR) | 294 (224, 360) |
mTICI | |
2b or 3, n (%) | 54 (77.1%) |
sICH, n (%) | 8 (11.4%) |
Neurological improvement, n (%) | 44 (62.9%) |
In-hospital mortality, n (%) | 10 (14.3%) |
3-month mRS score, median (IQR) | 3 (1, 5) |
3-month functional independence, n (%) | 28 (40%) |
3-month excellent functional outcome, n (%) | 20 (28.6%) |
3-month mortality, n (%) | 14 (20%) |
HCY, hemocyanin; CRP, C-reactive protein; FBG, fasting blood glucose; ICA, internal carotid artery; LAA, large artery atherosclerosis; CE, cardioembolism; SUE, stroke of undetermined cause; NIHSS, National Institute of Health Stroke Scale; mTICI, modified thrombolysis in cerebral infarction score; sICH, symptomatic intracerebral hemorrhage; ORT, onset to recanalization time; IQR, interquartile range.